Vaccine against Middle East respiratory syndrome coronavirus.
作者信息
Zumla Alimuddin, Memish Ziad A, Hui David S, Perlman Stanley
机构信息
Division of Infection and Immunity, Center for Clinical Microbiology, University College London, London, UK; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
Infectious Diseases Division, Department of Medicine and Department of Research, Prince Mohamed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia; Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
出版信息
Lancet Infect Dis. 2019 Oct;19(10):1054-1055. doi: 10.1016/S1473-3099(19)30477-3.
Abstract
摘要
相似文献
1
Vaccine against Middle East respiratory syndrome coronavirus.中东呼吸综合征冠状病毒疫苗
Lancet Infect Dis. 2019 Oct;19(10):1054-1055. doi: 10.1016/S1473-3099(19)30477-3.
2
Vaccine against Middle East respiratory syndrome coronavirus.中东呼吸综合征冠状病毒疫苗
Lancet Infect Dis. 2019 Oct;19(10):1053-1054. doi: 10.1016/S1473-3099(19)30476-1.
3
First clinical trial of a MERS coronavirus DNA vaccine.中东呼吸综合征冠状病毒DNA疫苗的首次临床试验。
Lancet Infect Dis. 2019 Sep;19(9):924-925. doi: 10.1016/S1473-3099(19)30397-4. Epub 2019 Jul 24.
4
Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.中东呼吸综合征冠状病毒疫苗的研发——进展与挑战。
Hum Vaccin Immunother. 2018 Feb 1;14(2):304-313. doi: 10.1080/21645515.2017.1389362. Epub 2017 Nov 29.
5
[Current Status of Middle East Respiratory Syndrome Vaccines].[中东呼吸综合征疫苗的现状]
Bing Du Xue Bao. 2016 Nov;32(6):825-9.
6
DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.编码中东呼吸综合征冠状病毒S1蛋白的DNA疫苗在小鼠中诱导保护性免疫反应。
Vaccine. 2017 Apr 11;35(16):2069-2075. doi: 10.1016/j.vaccine.2017.02.063. Epub 2017 Mar 14.
7
Middle East respiratory syndrome: current status and future prospects for vaccine development.中东呼吸综合征：疫苗研发的现状与未来前景
Expert Opin Biol Ther. 2015;15(11):1647-51. doi: 10.1517/14712598.2015.1092518. Epub 2015 Sep 28.
8
Progress toward a vaccine for Middle-Eastern respiratory syndrome.中东呼吸综合征疫苗的研发进展。
Viral Immunol. 2014 Dec;27(10):483. doi: 10.1089/vim.2014.1507.
9
MERS vaccine is technically feasible, but is it commerically feasible?中东呼吸综合征疫苗在技术上是可行的，但在商业上可行吗？
Hum Vaccin Immunother. 2014;10(6):1429-30.
10
Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.用于人类和骆驼的中东呼吸综合征冠状病毒疫苗。
Rev Med Virol. 2017 Mar;27(2). doi: 10.1002/rmv.1917. Epub 2016 Oct 27.
引用本文的文献
1
A global survey in the developmental landscape of possible vaccination strategies for COVID-19.全球调查 COVID-19 可能的疫苗接种策略的发展情况。
Clin Immunol. 2022 Apr;237:108958. doi: 10.1016/j.clim.2022.108958. Epub 2022 Feb 24.
2
Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?阿尔及利亚和北非国家新冠病毒的基因组多样性：我们目前所知及预期如何？
Microorganisms. 2022 Feb 18;10(2):467. doi: 10.3390/microorganisms10020467.
3
CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.CoronaVR：严重急性呼吸综合征冠状病毒2的表位与治疗方法的计算资源及分析
Front Microbiol. 2020 Jul 31;11:1858. doi: 10.3389/fmicb.2020.01858. eCollection 2020.
4
Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.冠状病毒：关于其复制与发病机制的最新综述
Methods Mol Biol. 2020;2203:1-29. doi: 10.1007/978-1-0716-0900-2_1.
5
Middle East Respiratory Syndrome - What Every Otolaryngologist Should Know: A Review.中东呼吸综合征——每位耳鼻喉科医生应知晓的内容：综述
Int J Gen Med. 2020 Jul 30;13:483-489. doi: 10.2147/IJGM.S252796. eCollection 2020.
6
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19.高通量、综合性方法研发针对致命性 COVID-19 的多表位疫苗。
Eur J Pharm Sci. 2020 Aug 1;151:105375. doi: 10.1016/j.ejps.2020.105375. Epub 2020 May 14.
7
Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China.中国武汉 2019 冠状病毒病患者疾病进展的特征。
Epidemiol Infect. 2020 May 6;148:e94. doi: 10.1017/S0950268820000977.
8
Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.SARS-CoV-2 的结构基因组学表明病毒蛋白的进化保守功能区。
Viruses. 2020 Mar 25;12(4):360. doi: 10.3390/v12040360.
本文引用的文献
1
First clinical trial of a MERS coronavirus DNA vaccine.中东呼吸综合征冠状病毒DNA疫苗的首次临床试验。
Lancet Infect Dis. 2019 Sep;19(9):924-925. doi: 10.1016/S1473-3099(19)30397-4. Epub 2019 Jul 24.
2
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.抗中东呼吸综合征冠状病毒 DNA 疫苗的安全性和免疫原性：一项 1 期、开放性、单臂、剂量递增试验。
Lancet Infect Dis. 2019 Sep;19(9):1013-1022. doi: 10.1016/S1473-3099(19)30266-X. Epub 2019 Jul 24.
3
Confronting the persisting threat of the Middle East respiratory syndrome to global health security.应对中东呼吸综合征对全球卫生安全持续构成的威胁。
Lancet Infect Dis. 2020 Feb;20(2):158-160. doi: 10.1016/S1473-3099(19)30347-0. Epub 2019 Jul 3.
4
Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.中东呼吸综合征疫苗候选者：谨慎乐观。
Viruses. 2019 Jan 17;11(1):74. doi: 10.3390/v11010074.
5
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission.中东呼吸综合征冠状病毒：原发性、家庭和医院传播的风险因素和决定因素。
Lancet Infect Dis. 2018 Aug;18(8):e217-e227. doi: 10.1016/S1473-3099(18)30127-0. Epub 2018 Apr 18.
6
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.新兴传染病疫苗：中东呼吸综合征冠状病毒和寨卡病毒带来的启示。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2918-2930. doi: 10.1080/21645515.2017.1358325. Epub 2017 Aug 28.
Zotero 插件